Journal of Shanghai Jiao Tong University (Medical Science) >
Values of fecal calprotectin, C-reactive protein and interleukin-6 in diagnosing gastrointestinal mucosal injury in patients with Crohn's disease
Received date: 2021-11-16
Online published: 2022-05-09
Supported by
National Natural Science Foundation of China(81702069);Cultivation Fund of Renji Hospital, Shanghai Jiao Tong University School of Medicine(PYIII-17-012)
·To investigate the values of fecal calprotectin (FC), C-reactive protein (CRP) and interleukin 6 (IL-6) in diagnosing the gastrointestinal mucosal injury in the patients with Crohn′s disease (CD).
·A total of 52 CD patients admitted to Renji Hospital, Shanghai Jiao Tong University School of Medicine from June 2019 to June 2020 were enrolled in the study. The patients were divided into uninjured mucosa group and injured mucosa group based on the gastrointestinal endoscopic results, and the clinical features of the two groups were compared. The level of IL-6 was detected by cytometric bead array. The content of FC was detected by immunofluorescence chromatography. CRP in the whole blood was detected by nephelometry. IL-6 and CRP were detected within 24 h of admission, while FC was detected within 72 h. The results were compared between the two groups. The independent influence factors of mucosal injury were analyzed by multivariate Logistic regression. The receiver operating characteristic (ROC) curve was used to determine the values of IL-6, CRP, FC and their combination in judging mucosal injury.
·Among the 52 patients, there were 21 patients in the uninjured mucosa group and 31 in the injured mucosa group. There were no significant differences in the age and gender between the two groups. The significant difference was only identified in the distribution of disease behavior in the Montreal Classification (P<0.05). The levels of IL-6, CRP and FC in the injured mucosa group were 11.1 (3.67, 17.54) pg/mL, 8.02 (2.13, 30.96) mg/L and 448.4 (212.90, 639.50) μg/g, respectively, which were significantly higher than those in the uninjured mucosa group (P<0.05). Logistic regression analysis suggested that only FC was an independent factor for judging the injured status of gastrointestinal mucosa in the CD patients (OR=1.006, P<0.05). The areas under the ROC curves (AUCs) of IL-6, CRP and FC for judging the state of gastrointestinal mucosal injury were 0.71, 0.88 and 0.85, respectively (all P<0.05). The AUCs of FC+CRP and FC+IL-6 were 0.91 and 0.84, respectively (both P<0.05). The AUC of FC+IL-6+CRP was 0.92 (P<0.05). By comparing the ROC curves of the two-item combined detection and the three-item combined detection, no significant difference could be identified in the AUC between FC+CRP and FC+IL-6+CRP. However, a significant difference was identified between FC+IL-6 and FC+IL-6+CRP (P=0.045). Meanwhile, the sensitivities and specificities of both FC+CRP and FC+IL-6+CRP were 77% and 100%, respectively.
·The combined detection of FC and CRP, as well as the combined detection of FC, IL-6 and CRP, can effectively judge the gastrointestinal mucosal injury in patients with CD, the diagnostic values of which are similar; based on the simplicity and the cost, the combined detection of FC and CRP is more recommended clinically.
Jirong MA , Wei SHEN , Yi GU , Wenyan SHEN , Jingyi ZHOU . Values of fecal calprotectin, C-reactive protein and interleukin-6 in diagnosing gastrointestinal mucosal injury in patients with Crohn's disease[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022 , 42(3) : 331 -336 . DOI: 10.3969/j.issn.1674-8115.2022.03.010
1 | 林丽琳, 王承党. 粪钙卫蛋白在炎症性肠病中的应用价值[J]. 胃肠病学, 2019, 24(4): 247-250. |
2 | 吴开春, 梁洁, 冉志华, 等. 炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]. 中国实用内科杂志, 2018, 38(9): 796-813. |
3 | GAJENDRAN M, LOGANATHAN P, CATINELLA A P, et al. A comprehensive review and update on Crohn's disease[J]. Dis Mon, 2018, 64(2): 20-57. |
4 | CHEN Y. Perspectives of IBD China: is Crohn's and colitis foundation model a solution to health care issues for the country? [J]. Inflamm Bowel Dis, 2018, 24(5): 925-929. |
5 | RIMOLA J, ORDáS I, RODRIGUEZ S, et al. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity[J]. Inflamm Bowel Dis, 2011, 17(8): 1759-1768. |
6 | POUS-SERRANO S, FRASSON M, PALASí GIMéNEZ R, et al. Accuracy of magnetic resonance enterography in the preoperative assessment of patients with Crohn's disease of the small bowel[J]. Colorectal Dis, 2017, 19(5): O126-O133. |
7 | MOOIWEER E, FIDDER H H, SIERSEMA P D, et al. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation[J]. Inflamm Bowel Dis, 2014, 20(2): 307-314. |
8 | POUS-SERRANO S, FRASSON M, CERRILLO E, et al. Correlation between fecal calprotectin and inflammation in the surgical specimen of Crohn's disease[J]. J Surg Res, 2017, 213: 290-297. |
9 | 曾俊祥, 吕婕, 罗婷, 等. 粪便钙卫蛋白检测及其实验影响因素[J]. 临床检验杂志, 2019, 37(10): 756-759. |
10 | MA C, BATTAT R, KHANNA R, et al. What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn's disease activity?[J]. Best Pract Res Clin Gastroenterol, 2019, 38/39: 101602. |
11 | NIKOLAUS S, WAETZIG G H, BUTZIN S, et al. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases[J]. Int J Colorectal Dis, 2018, 33(7): 927-936. |
12 | 马智聪. 白介素-6和白介素-2受体与克罗恩病活动性的关系[J]. 临床合理用药杂志, 2018, 11(2): 173-174. |
13 | 陈丹, 陈洋, 李骥, 等. 血清IL-6与TNF-α在克罗恩病疾病评估中的应用[J]. 胃肠病学和肝病学杂志, 2020, 29(3): 279-284. |
/
〈 |
|
〉 |